Invention Grant
- Patent Title: Methylation of the EPB41L3 gene or the promoter of the EPB41L3 gene in a test sample comprising cervical cells
-
Application No.: US15163422Application Date: 2016-05-24
-
Publication No.: US10041128B2Publication Date: 2018-08-07
- Inventor: Wim Van Criekinge , Valerie Deregowski , Luc Dehaspe , G. Bea A. Wisman , Ate G. J. Van der Zee , E. M. D. Schuuring
- Applicant: MDxHealth S.A.
- Applicant Address: BE Herstal
- Assignee: MD×Health SA
- Current Assignee: MD×Health SA
- Current Assignee Address: BE Herstal
- Agency: Andrus Intellectual Property Law, LLP
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12Q1/6886
Abstract:
The present invention relates to methods and kits for identifying, diagnosing, prognosing, and monitoring cervical cancer. These methods include determining the methylation status or the expression levels of particular genes, or a combination thereof.
Public/Granted literature
Information query
